Abstract
Purpose:
To describe the relationship between retinoblastoma differentiation, histopathological risk factors, age at enucleation, laterality, and genetic type (hereditary or sporadic) in a series of enucleated eyes in a referral hospital. The criteria used in other studies to classify retinoblastoma differentiation are discussed.
Methods:
The authors retrospectively studied histopathological preparations of eyes with retinoblastoma treated with primary enucleation. Tumors were classified as well differentiated, undifferentiated, and moderately differentiated. Patient age at enucleation, laterality of disease, genetic form (hereditary or sporadic), and presence of histopathological risk factors (massive choroidal infiltration, postlaminar optic nerve invasion, tumor in optic nerve cut, scleral invasion, and involvement of orbital soft tissues) were analyzed. The chi-square test was used for categorical variables and analysis of variance for test mean differences.
Results:
Histopathological risk factors were present in 23 (36%) of 63 eyes. Moderately differentiated tumors occurred at advanced ages and were more frequently associated with histopathological risk factors.
Conclusions:
A consensus is needed to establish the histopathological criteria of retinoblastoma differentiation. The value of rosettes as a marker of cell differentiation should be reviewed.
[J Pediatr Ophthalmol Strabismus 2013;50(3):174–177.]
- 1.Standard C, Lipper S, Sealy R, Seven D. Retinoblastoma: correlation of invasion of the optic nerve and choroid with prognosis and metastases. Br J Ophthalmol. 1979; 63:560–570
10.1136/bjo.63.8.560 . Crossref Medline, Google Scholar - 2.Eagle RC. High-risk features and tumor differentiation in retinoblastoma, a retrospective histopathologic study. Arch Pathol Lab Med. 2009; 133:1203–1209. Crossref Medline, Google Scholar
- 3.Leal-Leal C, Flores-Rojo M, Medina-Sansón A, A multicentre report from the Mexican retinoblastoma group. Br J Ophthalmol. 2004; 88:1074–1077
10.1136/bjo.2003.035642 . Crossref Medline, Google Scholar - 4.Sastre X, Chantada GL, Doz Francois , Proceedings of the consensus meetings from the international retinoblastoma staging working group on the pathology guidelines for the examination of enucleated eyes and evaluation of prognostic risk factors in retinoblastoma. Arch Pathol Lab Med. 2009; 133:1199–1202. Crossref Medline, Google Scholar
- 5.Madhavan J, Ganesh A, Roy J, Biswas J, Kumaramanickavel G. The relationship between tumor cell differentiation and age at diagnosis in retinoblastoma. J Pediatr Ophthalmol Strabismus. 2008; 45:22–25
10.3928/01913913-20080101-16 . Link, Google Scholar - 6.Arce CG, Erwenne CM, Saba LB. A model for the natural history of retinoblastoma according to its cellular differentiation [article in Portuguese]. Rev Bras Oftal. 2004; 64:93–103. Google Scholar
- 7.Kashyap S, Sethi G, Pushker N, Meel R, Sen S, Ghose S. Relationship between age at presentation, differentiation and high risk features in retinoblastoma.
Proceedings of the 69th Conference of All Indian Ophthalmological Society .February 3rd–6th, 2011 .All Indian Ophthalmological Society Ahmedabad, India ; 2011:834. Google Scholar - 8.Kashyap S, Sethi S, Meel R, A histopathologic analysis of eyes primarily enucleated for advanced intraocular retinoblastoma from a developing country. Arch Pathol Lab Med. 2012; 136:190–193
10.5858/arpa.2010-0759-OA . Crossref Medline, Google Scholar - 9.Gupta R, Vemuganti GK, Reddy VA, Honavar SG. Histopathologic risk factors in retinoblastoma in India. Arch Pathol Lab Med. 2009; 133:1210–1214. Crossref Medline, Google Scholar
- 10.Kashyap S, Meel R, Pushker N, Clinical predictors of high risk histopathology in retinoblastoma. Pediatr Blood Cancer. 2012; 58:356–361
10.1002/pbc.23239 . Crossref Medline, Google Scholar - 11.Orellana ME, Fernandes BF, Arean C, Pifano I, Al-kandari A, Burnier MN. Clinical pathologic study of a cohort of patients with retinoblastoma from a developing country. J Pediatr Ophthalmol Strabismus. 2009; 46:294–299
10.3928/01913913-20090903-07 . Link, Google Scholar - 12.Demirci H, Eagle RC, Shields CL, Shields JA. Histopathologic findings in eyes with retinoblastoma treated only with chemorreduction. Arch Ophthalmol. 2003; 121:1125–1131
10.1001/archopht.121.8.1125 . Crossref Medline, Google Scholar - 13.Schouten-van Meeteren AY, Van der Valk P, Van der Linden HC, Histopathologic features of retinoblastoma and its relation with in vitro drug resistance measured by jeans of the MTT Assay. Cancer. 2001; 92:2933–2940
10.1002/1097-0142(20011201)92:11<2933::AID-CNCR10071>3.0.CO;2-G . Crossref Medline, Google Scholar - 14.Filho JP, Correa ZM, Odashiro AN, Histopathological features and P-glycoprotein expression in retinoblastoma. Invest Ophthalmol Vis Sci. 2005; 46:3478–3483
10.1167/iovs.04-1290 . Crossref Medline, Google Scholar - 15.Krishnakumar S, Mallikarjuna K, Desai N, Multidrug resistant proteins: P-glycoprotein and lung resistance protein expression in retinoblastoma. Br J Ophthalmol. 2004; 88:1521–1526
10.1136/bjo.2004.047928 . Crossref Medline, Google Scholar - 16.Chong EM, Coffee RE, Chintagumpala M, Hurwitz RL, Hurwitz MY, Chévez-Barrios P. Extensively necrotic retinoblastoma is associated with high-risk prognostic factors. Arch Pathol Lab Med. 2006; 130:1669–1672. Crossref Medline, Google Scholar
- 17.Johnson DA, Zhang J, Frase S, Wilson M, Rodríguez-Galindo C, Dyer MA. Neuronal differentiation and synaptogenesis in retinoblastoma. Cancer Res. 2007; 67:2701–2711
10.1158/0008-5472.CAN-06-3754 . Crossref Medline, Google Scholar
